Startseite Topical dihydrotestosterone to treat micropenis secondary to partial androgen insensitivity syndrome (PAIS) before, during, and after puberty – a case series
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Topical dihydrotestosterone to treat micropenis secondary to partial androgen insensitivity syndrome (PAIS) before, during, and after puberty – a case series

  • David Becker , Lisa M. Wain , Yih Harng Chong , Sonal J. Gosai , Nina K. Henderson , Jacqui Milburn , Victoria Stott und Benjamin J. Wheeler EMAIL logo
Veröffentlicht/Copyright: 15. August 2015

Abstract

Background: X-linked partial androgen insensitivity syndrome (PAIS) causes under-virilization at all stages of development. In two thirds of males, this results in micropenis. Dihydrotestosterone (DHT) is a potent androgen that is critical for male genital development, which when applied topically, has been shown to increase penile length with micropenis of varying etiologies. We present the first case series using topical DHT gel to treat micropenis in 46,XY males with PAIS, before, during, and after puberty.

Methods: Three related 46,XY males with confirmed p.L712F androgen receptor mutations exhibited varying degrees of micropenis post-surgical correction. They were of pre-pubertal, peri-pubertal and adult ages, respectively. Following baseline clinical and laboratory assessments all completed a 4-month course of daily DHT gel 2.5% (androstanolone) topically to penis (0.3 mg/kg body weight), with monitoring for adverse effects. Primary outcome was change in stretched penile length (SPL) following treatment.

Results: Mixed results were obtained following topical DHT therapy. In the pre- and peri- pubertal patients, SPL changed from 2.5 cm to 3.5 cm (+40%), and 3.5 cm to 5.7 cm (+63%), respectively. In the adult patient with 1 year of prior high-dose weekly testosterone therapy, no additional change in SPL was seen. No adverse effects of topical DHT were reported or observed throughout the 4 months of treatment.

Conclusions: Topical DHT treatment appears to be a safe and well-tolerated method of virilising micropenis both prior to and during puberty in children with PAIS. Questions remain about long-term outcomes into adulthood, and efficacy in adults with prior lengthy exposure to high-dose testosterone.


Corresponding author: Dr. Benjamin J. Wheeler, Paediatric Endocrinologist, Department of Women’s and Children’s Health, University of Otago, PO Box 913, Dunedin 9054, New Zealand, Phone: 0064 3 4740999, Fax: 0064 3 4747817, E-mail: ; and Paediatric Endocrinology, Southern District Health Board, Dunedin, New Zealand

Acknowledgments

The authors wish to thank the participants and their families for their forbearance and generous participation.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Murashima A, Kishigami S, Thomson A, Yamada G. Androgens and mammalian male reproductive tract development. Biochimica et Biophysica Acta 2015;1849:163–70.10.1016/j.bbagrm.2014.05.020Suche in Google Scholar

2. Kumanov P, Robeva R, Tomova A. Prevalence of micropenis among boys from different regions of Bulgaria. J Pediatr Endocrinol Metab 2007;20:791–5.10.1515/JPEM.2007.20.7.791Suche in Google Scholar

3. Gottlieb B, Pinsky L, Beitel LK, Trifiro M. Androgen insensitivity. Am J Med Genet 1999;89:210–7.10.1002/(SICI)1096-8628(19991229)89:4<210::AID-AJMG5>3.0.CO;2-PSuche in Google Scholar

4. Gottlieb B, Beitel LK, Nadarajah A, Paliouras M, Trifiro M. The androgen receptor gene mutations database:2012 update. Hum Mutat 2012;33:887–94.10.1002/humu.22046Suche in Google Scholar

5. Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, et al. Androgen insensitivity syndrome. Lancet 2012;380:1419–28.10.1016/S0140-6736(12)60071-3Suche in Google Scholar

6. Holterhus PM, Sinnecker GH, Hiort O. Phenotypic diversity and testosterone-induced normalization of mutant L712F androgen receptor function in a kindred with androgen insensitivity. J Clin Endocrinol Metab 2000;85:3245–50.Suche in Google Scholar

7. Weidemann W, Peters B, Romalo G, Spindler KD, Schweikert HU. Response to androgen treatment in a patient with partial androgen insensitivity and a mutation in the deoxyribonucleic acid-binding domain of the androgen receptor. J Clin Endocrinol Metab 1998;83:1173–6.Suche in Google Scholar

8. Dougan GC, Uli N, Shulman DI. Progressive central puberty in a toddler with partial androgen insensitivity. J Pediatr 2014;164:655–7.10.1016/j.jpeds.2013.11.020Suche in Google Scholar

9. Hellmann P, Christiansen P, Johannsen TH, Main KM, Duno M, et al. Male patients with partial androgen insensitivity syndrome: a longitudinal follow-up of growth, reproductive hormones and the development of gynaecomastia. Arch Dis Child 2012;97:403–9.10.1136/archdischild-2011-300584Suche in Google Scholar

10. Choi SK, Han SW, Kim DH, de Lignieres B. Transdermal dihydrotestosterone therapy and its effects on patients with microphallus. J Urol 1993;150:657–60.10.1016/S0022-5347(17)35576-3Suche in Google Scholar

11. Charmandari E, Dattani MT, Perry LA, Hindmarsh PC, Brook CG. Kinetics and effect of percutaneous administration of dihydrotestosterone in children. Horm Res 2001;56:177–81.10.1159/000048115Suche in Google Scholar

12. Kaya C, Bektic J, Radmayr C, Schwentner C, Bartsch G, et al. The efficacy of dihydrotestosterone transdermal gel before primary hypospadias surgery: a prospective, controlled, randomized study. J Urol 2008;179:684–8.10.1016/j.juro.2007.09.098Suche in Google Scholar

13. Foresta C, Bettella A, Ferlin A, Garolla A, Moro E, et al. Response to local dihydrotestosterone treatment in a patient with partial androgen-insensitivity syndrome due to a novel mutation in the androgen receptor gene. Am J Med Genet 2002;107:259–60.10.1002/ajmg.10146Suche in Google Scholar PubMed

14. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, et al. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Res 1995;16:271–321.10.1210/edrv-16-3-271Suche in Google Scholar PubMed

15. Veale D, Miles S, Bramley S, Muir G, Hodsoll J. Am I normal? A systematic review and construction of nomograms for flaccid and erect penis length and circumference in up to 15 521 men. BJU International 2015;115:978–86.10.1111/bju.13010Suche in Google Scholar PubMed

16. Tomova A, Deepinder F, Robeva R, Lalabonova H, Kumanov P, et al. Growth and development of male external genitalia: a cross-sectional study of 6200 males aged 0 to 19 years. Arch Pediatr Adolesc Med 2010;164:1152–7.10.1001/archpediatrics.2010.223Suche in Google Scholar PubMed

17. van den Driesche S, Scott HM, MacLeod DJ, Fisken M, Walker M, et al. Relative importance of prenatal and postnatal androgen action in determining growth of the penis and anogenital distance in the rat before, during and after puberty. Int J Androl 2011;34:e578–86.10.1111/j.1365-2605.2011.01175.xSuche in Google Scholar PubMed

18. Macleod DJ, Sharpe RM, Welsh M, Fisken M, Scott HM, et al. Androgen action in the masculinization programming window and development of male reproductive organs. Int J Androl 2010;33:279–87.10.1111/j.1365-2605.2009.01005.xSuche in Google Scholar PubMed

19. Welsh M, MacLeod DJ, Walker M, Smith LB, Sharpe RM. Critical androgen-sensitive periods of rat penis and clitoris development. Int J Androl 2010;33:e144–52.10.1111/j.1365-2605.2009.00978.xSuche in Google Scholar PubMed PubMed Central

20. Patel A, Rivkees SA. Prenatal virilization associated with paternal testosterone gel therapy. Int J Pediatr Endocrinol 2010;2010:867471.10.1186/1687-9856-2010-867471Suche in Google Scholar

21. Lee PA, Houk CP. Outcome studies among men with micropenis. J Pediatr Endocrinol Metab 2004;17:1043–53.Suche in Google Scholar

22. Money J, Lehne GK, Pierre-Jerome F. Micropenis: adult follow-up and comparison of size against new norms. J Sex Marital Ther 1984;10:105–16.10.1080/00926238408405796Suche in Google Scholar PubMed

Received: 2015-4-24
Accepted: 2015-7-20
Published Online: 2015-8-15
Published in Print: 2016-2-1

©2016 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. REVIEW
  3. Obesity-associated sympathetic overactivity in children and adolescents: the role of catecholamine resistance in lipid metabolism
  4. MINI REVIEW
  5. Idiopathic infantile hypercalcemia: case report and review of the literature
  6. ORIGINAL ARTICLES
  7. Levothyroxine replacement in primary congenital hypothyroidism: the higher the initial dose the higher the rate of overtreatment
  8. Effect of auditory guided imagery on glucose levels and on glycemic control in children with type 1 diabetes mellitus
  9. Kidney injury molecule-1 and neutrophil gelatinase associated lipocalin in normoalbuminuric diabetic children
  10. Use of the triglyceride to HDL cholesterol ratio for assessing insulin sensitivity in overweight and obese children in rural Appalachia
  11. Carotid intima media thickness in obese children: is there an association with hyperlipidemia?
  12. Schoolchildren born VLBW or VLGA show height-related changes in body composition and muscle function but no evidence of metabolic syndrome risk factors. Results from the NEOLONG study
  13. Topical dihydrotestosterone to treat micropenis secondary to partial androgen insensitivity syndrome (PAIS) before, during, and after puberty – a case series
  14. Urinary myo-inositol levels in Japanese schoolchildren with normal glucose tolerance
  15. Barriers in communication and available resources to facilitate conversation about infertility with girls diagnosed with Turner syndrome
  16. Analysis of the PAX8 gene in 32 children with thyroid dysgenesis and functional characterization of a promoter variant
  17. Decrease of small dense LDL and lipoprotein-associated phospholipase A2 due to human growth hormone treatment in short children with growth hormone deficiency and small for gestational age status
  18. Rare and curable renin-mediated hypertension: a series of six cases and a literature review
  19. CASE REPORTS
  20. Vulvar fetal rhabdomyoma mimicking 46XX sex differentiation disorder
  21. Simultaneous occurrence of diabetic ketoacidosis, thyroid storm, and multiple cerebral infarctions due to Moyamoya disease
  22. Brown-Vialetto-Van Laere syndrome: two siblings with a new mutation and dramatic therapeutic effect of high-dose riboflavin
  23. Lipomatous nevus and urethral caruncle mistaken for ambiguous genitalia in a female infant
  24. Thyrotropin-secreting pituitary adenoma in an 11-year-old boy with type 1 autoimmune polyglandular syndrome
  25. Changes in facial appearance from neonate to adult in 3-M syndrome patient with novel CUL7 gene mutations
Heruntergeladen am 26.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2015-0175/html
Button zum nach oben scrollen